Goldman Sachs’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12M | Buy |
225,856
+95,105
| +73% | +$5.04M | ﹤0.01% | 2143 |
|
2025
Q1 | $6.49M | Sell |
130,751
-41,059
| -24% | -$2.04M | ﹤0.01% | 2555 |
|
2024
Q4 | $10.9M | Buy |
171,810
+244
| +0.1% | +$15.5K | ﹤0.01% | 2260 |
|
2024
Q3 | $8.43M | Buy |
171,566
+117,319
| +216% | +$5.77M | ﹤0.01% | 2397 |
|
2024
Q2 | $2.44M | Sell |
54,247
-14,156
| -21% | -$638K | ﹤0.01% | 3079 |
|
2024
Q1 | $4.26M | Buy |
68,403
+6,228
| +10% | +$388K | ﹤0.01% | 2700 |
|
2023
Q4 | $3.59M | Buy |
62,175
+34,821
| +127% | +$2.01M | ﹤0.01% | 2822 |
|
2023
Q3 | $1.29M | Buy |
+27,354
| New | +$1.29M | ﹤0.01% | 3373 |
|
2023
Q2 | – | Sell |
-21,674
| Closed | -$459K | – | 5044 |
|
2023
Q1 | $459K | Buy |
+21,674
| New | +$459K | ﹤0.01% | 4110 |
|
2022
Q4 | – | Sell |
-650
| Closed | -$32K | – | 5266 |
|
2022
Q3 | $32K | Sell |
650
-571
| -47% | -$28.1K | ﹤0.01% | 5084 |
|
2022
Q2 | $62K | Buy |
1,221
+543
| +80% | +$27.6K | ﹤0.01% | 5232 |
|
2022
Q1 | $28K | Sell |
678
-1,748
| -72% | -$72.2K | ﹤0.01% | 5565 |
|
2021
Q4 | $212K | Buy |
2,426
+1,929
| +388% | +$169K | ﹤0.01% | 4968 |
|
2021
Q3 | $60K | Buy |
497
+61
| +14% | +$7.36K | ﹤0.01% | 5150 |
|
2021
Q2 | $85K | Sell |
436
-879
| -67% | -$171K | ﹤0.01% | 5152 |
|
2021
Q1 | $535K | Buy |
+1,315
| New | +$535K | ﹤0.01% | 4307 |
|